| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 2.58e-07 | 8 | 158 | 4 | GO:0098882 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 3.94e-05 | 9 | 158 | 3 | GO:0141038 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.29e-04 | 188 | 158 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 2.52e-04 | 16 | 158 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.34e-04 | 42 | 158 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 3.63e-04 | 18 | 158 | 3 | GO:0035014 | |
| GeneOntologyMolecularFunction | virus receptor activity | 5.74e-04 | 85 | 158 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 6.05e-04 | 86 | 158 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.06e-04 | 49 | 158 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I binding | 6.13e-04 | 5 | 158 | 2 | GO:0034186 | |
| GeneOntologyMolecularFunction | structural molecule activity | NPHP1 COL7A1 COL10A1 PCLO NUP98 LAMA5 MMRN1 TUBB4B THBS3 YEATS4 ACAN SORBS3 COL14A1 RIMS1 BSN RIMS2 ZP4 | 7.11e-04 | 891 | 158 | 17 | GO:0005198 |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 8.51e-06 | 6 | 157 | 3 | GO:0048790 | |
| GeneOntologyBiologicalProcess | exocytic process | 1.79e-05 | 107 | 157 | 7 | GO:0140029 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NPHP1 BOC ABCA12 NT5E NLGN4Y CELA2A CAMSAP3 NCAM1 CD46 MMRN1 NLGN3 NLGN4X ELFN1 PIK3R1 ADAMTS18 PDIA2 COL14A1 CD81 LYN ZP4 SDK1 FOXF1 | 2.30e-05 | 1077 | 157 | 22 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 4.99e-05 | 10 | 157 | 3 | GO:0097151 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 4.99e-05 | 10 | 157 | 3 | GO:1990709 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 4.99e-05 | 10 | 157 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 6.25e-05 | 130 | 157 | 7 | GO:0060079 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 6.83e-05 | 11 | 157 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | synapse organization | NLGN4Y PCLO APBB1 LAMA5 CAMK1 OPHN1 NEDD9 NLGN3 NLGN4X PTPRO ELFN1 PIK3R1 AFG3L2 BSN RIMS2 SDK1 | 7.05e-05 | 685 | 157 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 9.05e-05 | 12 | 157 | 3 | GO:0098828 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 9.34e-05 | 60 | 157 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.17e-04 | 13 | 157 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.23e-04 | 101 | 157 | 6 | GO:0043954 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.35e-04 | 147 | 157 | 7 | GO:0099565 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.37e-04 | 65 | 157 | 5 | GO:0098815 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 1.37e-04 | 65 | 157 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | cell junction organization | NPHP1 NLGN4Y PCLO FRMPD2 CAMSAP3 APBB1 LAMA5 CAMK1 OPHN1 NEDD9 NLGN3 NLGN4X PTPRO ELFN1 PIK3R1 AFG3L2 BSN RIMS2 SDK1 | 1.58e-04 | 974 | 157 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | cellular response to endothelin | 1.72e-04 | 3 | 157 | 2 | GO:1990859 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.72e-04 | 3 | 157 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.72e-04 | 3 | 157 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.80e-04 | 321 | 157 | 10 | GO:0099003 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 1.96e-04 | 264 | 157 | 9 | GO:0099504 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.25e-04 | 16 | 157 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 2.37e-04 | 73 | 157 | 5 | GO:0001738 | |
| GeneOntologyBiologicalProcess | presynapse organization | 2.37e-04 | 73 | 157 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 2.39e-04 | 40 | 157 | 4 | GO:0099558 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.89e-04 | 42 | 157 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell polarity | 2.89e-04 | 42 | 157 | 4 | GO:0090162 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 3.42e-04 | 4 | 157 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 3.42e-04 | 4 | 157 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 3.46e-04 | 44 | 157 | 4 | GO:0006904 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.77e-04 | 124 | 157 | 6 | GO:0034109 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 4.01e-04 | 291 | 157 | 9 | GO:0045055 | |
| GeneOntologyBiologicalProcess | cell junction assembly | NPHP1 NLGN4Y PCLO FRMPD2 CAMSAP3 OPHN1 NLGN3 NLGN4X PTPRO ELFN1 PIK3R1 BSN SDK1 | 4.24e-04 | 569 | 157 | 13 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 4.66e-04 | 180 | 157 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell apical/basal polarity | 5.20e-04 | 21 | 157 | 3 | GO:0045198 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 5.67e-04 | 5 | 157 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | response to endothelin | 5.67e-04 | 5 | 157 | 2 | GO:1990839 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 5.99e-04 | 22 | 157 | 3 | GO:0097091 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.78e-09 | 31 | 158 | 7 | GO:0060077 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 2.15e-07 | 8 | 158 | 4 | GO:0048788 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.95e-07 | 164 | 158 | 10 | GO:0098982 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.69e-06 | 4 | 158 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | somatodendritic compartment | BOC FLNB SRSF10 CAD HTR3A CALCR NLGN4Y PCLO APBB1 NCAM1 PABPC1 OPHN1 GRIP1 BPTF NLGN3 NLGN4X PTPRO ELFN1 ACAN MAST1 C4A C4B BSN USH2A FUBP3 GOT2 | 1.74e-06 | 1228 | 158 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 2.96e-06 | 14 | 158 | 4 | GO:0099569 | |
| GeneOntologyCellularComponent | glutamatergic synapse | HTR3A NLGN4Y PCLO APBB1 LAMA5 NCAM1 CAMK1 OPHN1 GRIP1 NLGN3 NLGN4X PTPRO ELFN1 ACAN RIMS1 BSN CADPS2 LYN RIMS2 | 1.37e-05 | 817 | 158 | 19 | GO:0098978 |
| GeneOntologyCellularComponent | excitatory synapse | 1.71e-05 | 107 | 158 | 7 | GO:0060076 | |
| GeneOntologyCellularComponent | neuronal cell body | BOC FLNB SRSF10 CAD HTR3A CALCR PCLO APBB1 NCAM1 GRIP1 NLGN3 ACAN MAST1 C4A C4B BSN USH2A FUBP3 GOT2 | 1.86e-05 | 835 | 158 | 19 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | BOC FLNB SRSF10 CAD HTR3A CALCR PCLO APBB1 NCAM1 GRIP1 BPTF NLGN3 ACAN MAST1 C4A C4B BSN USH2A FUBP3 GOT2 | 2.44e-05 | 929 | 158 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.49e-05 | 23 | 158 | 4 | GO:0098831 | |
| GeneOntologyCellularComponent | synaptic membrane | HTR3A CHRNA9 NT5E NLGN4Y APBB1 NCAM1 GRIP1 NLGN3 NLGN4X PTPRO ELFN1 RIMS1 BSN CADPS2 RIMS2 | 3.76e-05 | 583 | 158 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | extracellular matrix | COL7A1 COL10A1 CELA2A LAMA5 NCAM1 F13A1 MMRN1 THBS3 ADAMTS7 ELFN1 ACAN ADAMTS18 COL14A1 PZP ZP4 USH2A | 3.90e-05 | 656 | 158 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL7A1 COL10A1 CELA2A LAMA5 NCAM1 F13A1 MMRN1 THBS3 ADAMTS7 ELFN1 ACAN ADAMTS18 COL14A1 PZP ZP4 USH2A | 4.04e-05 | 658 | 158 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | presynapse | SRSF10 CAD HTR3A SLC2A8 NLGN4Y PCLO APBB1 NCAM1 OPHN1 GRIP1 NLGN3 STXBP2 NLGN4X ELFN1 RIMS1 BSN CADPS2 RIMS2 USH2A | 4.17e-05 | 886 | 158 | 19 | GO:0098793 |
| GeneOntologyCellularComponent | symmetric synapse | 1.15e-04 | 13 | 158 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | axon | BOC SRSF10 CAD HTR3A CALCR PCLO APBB1 NCAM1 BCAR1 OPHN1 GRIP1 PTPRO ELFN1 MAST1 C4A C4B BSN USH2A | 1.43e-04 | 891 | 158 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | anchoring collagen complex | 1.69e-04 | 3 | 158 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL7A1 COL10A1 CELA2A LAMA5 NCAM1 F13A1 MMRN1 THBS3 ACAN COL14A1 PZP ZP4 USH2A | 2.01e-04 | 530 | 158 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL7A1 COL10A1 ERP44 UGGT1 ADAMTS7 EDEM2 PDIA2 COL14A1 C4A PRKCSH | 2.24e-04 | 332 | 158 | 10 | GO:0005788 |
| GeneOntologyCellularComponent | postsynaptic membrane | HTR3A CHRNA9 NLGN4Y APBB1 NCAM1 GRIP1 NLGN3 NLGN4X PTPRO ELFN1 CADPS2 | 2.66e-04 | 405 | 158 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | dendrite | SRSF10 NLGN4Y PCLO APBB1 PABPC1 OPHN1 GRIP1 BPTF NLGN3 NLGN4X PTPRO ELFN1 MAST1 C4A C4B BSN FUBP3 | 2.76e-04 | 858 | 158 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SRSF10 NLGN4Y PCLO APBB1 PABPC1 OPHN1 GRIP1 BPTF NLGN3 NLGN4X PTPRO ELFN1 MAST1 C4A C4B BSN FUBP3 | 2.84e-04 | 860 | 158 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | cell cortex region | 3.68e-04 | 45 | 158 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | neuron projection terminus | 4.06e-04 | 233 | 158 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | anchoring junction | NPHP1 FLNB FRMPD2 CAMSAP3 NCAM1 CD46 BCAR1 MAST2 PABPC1 KRIT1 NEDD9 FRMD4A PIK3R1 SORBS3 CD81 PRKD1 LYN CNN1 | 4.30e-04 | 976 | 158 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | postsynaptic specialization | CHRNA9 NLGN4Y PCLO CAMK1 GRIP1 NLGN3 NLGN4X PTPRO ELFN1 RIMS1 BSN LYN | 4.55e-04 | 503 | 158 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | distal axon | BOC SRSF10 CAD PCLO APBB1 NCAM1 OPHN1 GRIP1 PTPRO ELFN1 USH2A | 4.86e-04 | 435 | 158 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | cell cortex | 5.37e-04 | 371 | 158 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 7.63e-04 | 24 | 158 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | terminal bouton | 8.14e-04 | 96 | 158 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | axon terminus | 1.11e-03 | 210 | 158 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.54e-03 | 8 | 158 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 1.54e-03 | 8 | 158 | 2 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 1.54e-03 | 8 | 158 | 2 | GO:0071756 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.79e-03 | 32 | 158 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | postsynapse | HTR3A CHRNA9 NLGN4Y PCLO APBB1 NCAM1 CAMK1 OPHN1 GRIP1 NLGN3 NLGN4X PTPRO ELFN1 RIMS1 BSN CADPS2 LYN | 1.83e-03 | 1018 | 158 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | other organism part | 1.97e-03 | 9 | 158 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 1.97e-03 | 9 | 158 | 2 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 2.45e-03 | 10 | 158 | 2 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 2.45e-03 | 10 | 158 | 2 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 2.45e-03 | 10 | 158 | 2 | GO:0071751 | |
| GeneOntologyCellularComponent | peptidase complex | 3.42e-03 | 133 | 158 | 5 | GO:1905368 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.46e-03 | 477 | 158 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 4.19e-03 | 13 | 158 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.30e-03 | 201 | 158 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 4.39e-03 | 141 | 158 | 5 | GO:0005793 | |
| GeneOntologyCellularComponent | presynaptic active zone | 4.39e-03 | 141 | 158 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | blood microparticle | 4.80e-03 | 144 | 158 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | presynaptic membrane | 5.20e-03 | 277 | 158 | 7 | GO:0042734 | |
| Domain | DUF1908 | 2.23e-06 | 4 | 155 | 3 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.23e-06 | 4 | 155 | 3 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.23e-06 | 4 | 155 | 3 | IPR023142 | |
| Domain | - | 2.23e-06 | 4 | 155 | 3 | 1.20.1480.20 | |
| Domain | Nlgn | 5.54e-06 | 5 | 155 | 3 | IPR000460 | |
| Domain | PDZ | 3.83e-05 | 151 | 155 | 8 | PS50106 | |
| Domain | PDZ | 4.01e-05 | 152 | 155 | 8 | IPR001478 | |
| Domain | A2M | 6.45e-05 | 10 | 155 | 3 | PF00207 | |
| Domain | A2M_N_2 | 6.45e-05 | 10 | 155 | 3 | IPR011625 | |
| Domain | A2M_comp | 6.45e-05 | 10 | 155 | 3 | IPR011626 | |
| Domain | A2M_recep | 6.45e-05 | 10 | 155 | 3 | PF07677 | |
| Domain | A2M_comp | 6.45e-05 | 10 | 155 | 3 | PF07678 | |
| Domain | A2M_N | 6.45e-05 | 10 | 155 | 3 | PF01835 | |
| Domain | A2M_N | 6.45e-05 | 10 | 155 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 6.45e-05 | 10 | 155 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 6.45e-05 | 10 | 155 | 3 | PS00477 | |
| Domain | A2M_N_2 | 6.45e-05 | 10 | 155 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 6.45e-05 | 10 | 155 | 3 | IPR001599 | |
| Domain | NLGN4 | 6.84e-05 | 2 | 155 | 2 | IPR030025 | |
| Domain | Znf_piccolo | 6.84e-05 | 2 | 155 | 2 | IPR008899 | |
| Domain | zf-piccolo | 6.84e-05 | 2 | 155 | 2 | PF05715 | |
| Domain | Carboxylesterase_B_CS | 1.51e-04 | 13 | 155 | 3 | IPR019819 | |
| Domain | PDZ | 1.77e-04 | 141 | 155 | 7 | PF00595 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.91e-04 | 14 | 155 | 3 | PS00941 | |
| Domain | COesterase | 1.91e-04 | 14 | 155 | 3 | PF00135 | |
| Domain | CarbesteraseB | 1.91e-04 | 14 | 155 | 3 | IPR002018 | |
| Domain | Serine_rich | 2.04e-04 | 3 | 155 | 2 | IPR014928 | |
| Domain | Serine_rich | 2.04e-04 | 3 | 155 | 2 | PF08824 | |
| Domain | PDZ | 2.38e-04 | 148 | 155 | 7 | SM00228 | |
| Domain | - | 2.58e-04 | 150 | 155 | 7 | 2.30.42.10 | |
| Domain | BTB | 3.82e-04 | 160 | 155 | 7 | PS50097 | |
| Domain | Pkinase_C | 4.00e-04 | 42 | 155 | 4 | PF00433 | |
| Domain | ABC_transporter_CS | 4.00e-04 | 42 | 155 | 4 | IPR017871 | |
| Domain | CAS_DUF3513 | 4.06e-04 | 4 | 155 | 2 | IPR021901 | |
| Domain | DUF3513 | 4.06e-04 | 4 | 155 | 2 | PF12026 | |
| Domain | fn3 | 4.12e-04 | 162 | 155 | 7 | PF00041 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.17e-04 | 18 | 155 | 3 | IPR008930 | |
| Domain | SH3_1 | 4.44e-04 | 164 | 155 | 7 | PF00018 | |
| Domain | ConA-like_dom | 4.95e-04 | 219 | 155 | 8 | IPR013320 | |
| Domain | ER_TARGET | 6.17e-04 | 47 | 155 | 4 | PS00014 | |
| Domain | ABC_tran | 6.68e-04 | 48 | 155 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.68e-04 | 48 | 155 | 4 | PS50893 | |
| Domain | Anaphylatoxin_comp_syst | 6.73e-04 | 5 | 155 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 6.73e-04 | 5 | 155 | 2 | IPR001840 | |
| Domain | ABC_TRANSPORTER_1 | 7.23e-04 | 49 | 155 | 4 | PS00211 | |
| Domain | BTB | 7.72e-04 | 180 | 155 | 7 | SM00225 | |
| Domain | ABC_transporter-like | 7.81e-04 | 50 | 155 | 4 | IPR003439 | |
| Domain | BTB | 7.90e-04 | 131 | 155 | 6 | PF00651 | |
| Domain | BTB/POZ_dom | 9.06e-04 | 185 | 155 | 7 | IPR000210 | |
| Domain | FN3 | 9.06e-04 | 185 | 155 | 7 | SM00060 | |
| Domain | SKP1/BTB/POZ | 1.03e-03 | 189 | 155 | 7 | IPR011333 | |
| Domain | AGC-kinase_C | 1.20e-03 | 56 | 155 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.20e-03 | 56 | 155 | 4 | PS51285 | |
| Domain | S_TK_X | 1.20e-03 | 56 | 155 | 4 | SM00133 | |
| Domain | AAA | 1.29e-03 | 144 | 155 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.29e-03 | 144 | 155 | 6 | IPR003593 | |
| Domain | Laminin_G | 1.37e-03 | 58 | 155 | 4 | IPR001791 | |
| Domain | FN3 | 1.38e-03 | 199 | 155 | 7 | PS50853 | |
| Domain | ANATO | 1.40e-03 | 7 | 155 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.40e-03 | 7 | 155 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.40e-03 | 7 | 155 | 2 | PS01177 | |
| Domain | ANATO | 1.40e-03 | 7 | 155 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.40e-03 | 7 | 155 | 2 | IPR000020 | |
| Domain | Znf_FYVE_PHD | 1.43e-03 | 147 | 155 | 6 | IPR011011 | |
| Domain | FN3_dom | 1.83e-03 | 209 | 155 | 7 | IPR003961 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.85e-03 | 8 | 155 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.85e-03 | 8 | 155 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.85e-03 | 8 | 155 | 2 | IPR019742 | |
| Domain | SH3 | 2.20e-03 | 216 | 155 | 7 | SM00326 | |
| Domain | SH3 | 2.20e-03 | 216 | 155 | 7 | PS50002 | |
| Domain | SH3_domain | 2.44e-03 | 220 | 155 | 7 | IPR001452 | |
| Domain | RNaseH-like_dom | 2.60e-03 | 69 | 155 | 4 | IPR012337 | |
| Domain | - | 3.16e-03 | 119 | 155 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.16e-03 | 119 | 155 | 5 | IPR029058 | |
| Domain | FYVE_2 | 3.58e-03 | 11 | 155 | 2 | PF02318 | |
| Domain | ABC_A | 4.28e-03 | 12 | 155 | 2 | IPR026082 | |
| Domain | RABBD | 4.28e-03 | 12 | 155 | 2 | PS50916 | |
| Domain | Rab_BD | 4.28e-03 | 12 | 155 | 2 | IPR010911 | |
| Domain | Kinase-like_dom | SMG1 CAMK1 CHKB MAST2 LATS2 TBCK MAST1 PRKD1 LYN FOXF1 MAST3 | 5.62e-03 | 542 | 155 | 11 | IPR011009 |
| Domain | FERM_M | 6.55e-03 | 46 | 155 | 3 | PF00373 | |
| Domain | Spectrin_alpha_SH3 | 6.69e-03 | 15 | 155 | 2 | IPR013315 | |
| Domain | - | 6.96e-03 | 47 | 155 | 3 | 3.30.420.10 | |
| Domain | Laminin_N | 7.61e-03 | 16 | 155 | 2 | IPR008211 | |
| Domain | LamNT | 7.61e-03 | 16 | 155 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 7.61e-03 | 16 | 155 | 2 | PS51117 | |
| Domain | Laminin_N | 7.61e-03 | 16 | 155 | 2 | PF00055 | |
| Domain | - | 7.81e-03 | 49 | 155 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 7.81e-03 | 49 | 155 | 3 | IPR019748 | |
| Domain | FERM_domain | 7.81e-03 | 49 | 155 | 3 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 8.26e-03 | 50 | 155 | 3 | IPR014352 | |
| Domain | FERM_1 | 8.26e-03 | 50 | 155 | 3 | PS00660 | |
| Domain | FERM_2 | 8.26e-03 | 50 | 155 | 3 | PS00661 | |
| Domain | FERM_3 | 8.26e-03 | 50 | 155 | 3 | PS50057 | |
| Domain | Band_41_domain | 8.26e-03 | 50 | 155 | 3 | IPR019749 | |
| Domain | B41 | 8.26e-03 | 50 | 155 | 3 | SM00295 | |
| Pubmed | TTLL3 RNGTT PMPCB UGGT1 CELA2A CA14 REV3L METTL26 F13A1 CLCC1 RYR1 OPHN1 NEDD9 FRMD4A NLGN3 CLYBL EDEM2 CD81 MRPL40 PRKCSH CADPS2 RIMS2 TCTN1 TP53BP1 AFG1L | 1.16e-09 | 1293 | 159 | 25 | 15342556 | |
| Pubmed | 9.02e-09 | 90 | 159 | 8 | 31280863 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 SRSF10 CAD PMPCB HSPA4L PCLO PSMB7 NUP98 APBB1 PSMC4 PYM1 NDUFB8 KBTBD7 CLCC1 IBTK FAM120A CLYBL PIK3R1 AFG3L2 MRPL40 PRKCSH DDHD2 FUBP3 NEURL4 GPAT4 | 2.11e-08 | 1496 | 159 | 25 | 32877691 |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 32011705 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 18628683 | ||
| Pubmed | SMG1 FLNB MYH7 SRSF10 PMPCB HSPA4L PCLO UGGT1 CAMSAP3 NUP98 ABCC5 PRPF8 PABPC1 BPTF LATS2 STXBP2 ABCB9 PDIA2 RIMS1 BSN CADPS2 RIMS2 FUBP3 | 1.89e-07 | 1442 | 159 | 23 | 35575683 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 34461308 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 15951562 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 3.74e-07 | 4 | 159 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 3.74e-07 | 4 | 159 | 3 | 22671294 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 20579107 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 16077734 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 17292328 | ||
| Pubmed | PDXDC1 FLNB CAD ERP44 UGGT1 LAMA5 PSMC4 AGPS PRPF8 PABPC1 BPTF TUBB4B FAM120A SCARB1 AFG3L2 SORBS3 MRPL40 PRKCSH LYN GOT2 TP53BP1 | 5.35e-07 | 1297 | 159 | 21 | 33545068 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 9.31e-07 | 5 | 159 | 3 | 10996085 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB SRSF10 CAD ERP44 UGGT1 NUP98 AGPS PRPF8 PABPC1 BPTF TUBB4B STXBP2 AFG3L2 PRKCSH LYN FUBP3 NEURL4 GOT2 | 1.17e-06 | 1024 | 159 | 18 | 24711643 |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 21838267 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 19812333 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 29724786 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 14734538 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB SRSF10 CAD ERP44 PMPCB HSPA4L PCLO UGGT1 NUP98 PSMC4 AGPS PRPF8 MAST2 NHP2 PABPC1 FAM120A ADSS2 PRKCSH BSN FUBP3 GOT2 | 2.38e-06 | 1425 | 159 | 21 | 30948266 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 FLNB RNGTT ERP44 PMPCB HSPA4L UGGT1 DUSP5 PSMB7 NUP98 PSMC4 PRPF8 FAM120A PTPRO AFG3L2 PRKCSH FUBP3 | 2.60e-06 | 974 | 159 | 17 | 28675297 |
| Pubmed | FLNB CAD HSPA4L UGGT1 PSMC4 PABPC1 BPTF TUBB4B FAM120A AGO3 PRKCSH TP53BP1 | 3.19e-06 | 494 | 159 | 12 | 26831064 | |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 9020138 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNB ERP44 HSPA4L UGGT1 PRPF8 PABPC1 TUBB4B FAM120A STXBP2 TP53BP1 | 4.56e-06 | 344 | 159 | 10 | 30333137 |
| Pubmed | CAD PMPCB HSPA4L UGGT1 APBB1 PSMC4 PYM1 PRPF8 NDUFB8 CLCC1 FAM120A PIK3R1 AFG3L2 COL14A1 MRPL40 PRKCSH DDHD2 NEURL4 GPAT4 TP53BP1 MAST3 | 4.60e-06 | 1487 | 159 | 21 | 33957083 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 5.16e-06 | 8 | 159 | 3 | 30871858 | |
| Pubmed | 5.16e-06 | 8 | 159 | 3 | 14670299 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 5.81e-06 | 26 | 159 | 4 | 34848499 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.38e-06 | 281 | 159 | 9 | 28706196 | |
| Pubmed | 7.72e-06 | 9 | 159 | 3 | 21144999 | ||
| Pubmed | 7.72e-06 | 9 | 159 | 3 | 23010509 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | SMG1 CAD PCLO UGGT1 PSMB7 PSMC4 PRPF8 PABPC1 MMRN1 TUBB4B FAM120A MRPL40 NEURL4 | 8.38e-06 | 639 | 159 | 13 | 23443559 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SRSF10 PCLO CHSY1 PYM1 MAST2 PABPC1 FAM120A AGO3 PRKD1 SLC25A19 GPAT4 | 1.00e-05 | 462 | 159 | 11 | 31138677 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL7A1 GALNT3 ERP44 ANPEP HSPA4L UGGT1 LAMA5 CHSY1 MANEA CD46 CLCC1 IGSF10 THBS3 SCARB1 EDEM2 C4A PRKCSH GPAT4 | 1.06e-05 | 1201 | 159 | 18 | 35696571 |
| Pubmed | 1.10e-05 | 10 | 159 | 3 | 24436304 | ||
| Pubmed | 1.10e-05 | 10 | 159 | 3 | 36357400 | ||
| Pubmed | 1.20e-05 | 31 | 159 | 4 | 15217342 | ||
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 32973045 | ||
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 26403076 | ||
| Pubmed | 1.70e-05 | 175 | 159 | 7 | 28071719 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | FLNB CAD ERP44 HSPA4L UGGT1 PSMB7 PSMC4 KBTBD7 TUBB4B ADSS2 PRKCSH | 1.90e-05 | 495 | 159 | 11 | 28581483 |
| Pubmed | 2.00e-05 | 12 | 159 | 3 | 28700933 | ||
| Pubmed | 2.00e-05 | 12 | 159 | 3 | 29287114 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.08e-05 | 2 | 159 | 2 | 16565498 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15998580 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19062096 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 9245798 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 27782075 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.08e-05 | 2 | 159 | 2 | 19933335 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.08e-05 | 2 | 159 | 2 | 23403927 | |
| Pubmed | Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation. | 2.08e-05 | 2 | 159 | 2 | 28948087 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.08e-05 | 2 | 159 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.08e-05 | 2 | 159 | 2 | 17645767 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19837407 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12207352 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19148942 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.08e-05 | 2 | 159 | 2 | 27758680 | |
| Pubmed | Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. | 2.08e-05 | 2 | 159 | 2 | 22802462 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16192289 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22387014 | ||
| Pubmed | Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. | 2.08e-05 | 2 | 159 | 2 | 16648374 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.08e-05 | 2 | 159 | 2 | 26793095 | |
| Pubmed | A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. | 2.08e-05 | 2 | 159 | 2 | 19645625 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.08e-05 | 2 | 159 | 2 | 23749435 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.08e-05 | 2 | 159 | 2 | 3037333 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11726230 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 4216347 | ||
| Pubmed | RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction. | 2.08e-05 | 2 | 159 | 2 | 25240052 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.08e-05 | 2 | 159 | 2 | 6950384 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 20332206 | ||
| Pubmed | Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. | 2.08e-05 | 2 | 159 | 2 | 15274046 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.08e-05 | 2 | 159 | 2 | 8428773 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16647293 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24638111 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22015197 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.08e-05 | 2 | 159 | 2 | 21345967 | |
| Pubmed | Influence of birth weight on internalizing traits modulated by serotonergic genes. | 2.08e-05 | 2 | 159 | 2 | 21969281 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23183221 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.08e-05 | 2 | 159 | 2 | 21935939 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24855039 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 2572548 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 2302180 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 2.08e-05 | 2 | 159 | 2 | 37001827 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.08e-05 | 2 | 159 | 2 | 18091514 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29080553 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.08e-05 | 2 | 159 | 2 | 25339671 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17728371 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 6149580 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 6149581 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12115608 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 3542363 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 2387317 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16908004 | ||
| GeneFamily | PDZ domain containing | 5.74e-06 | 152 | 115 | 8 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 8.37e-06 | 160 | 115 | 8 | 555 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.05e-05 | 9 | 115 | 3 | 1234 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.36e-05 | 134 | 115 | 7 | 861 | |
| GeneFamily | Cas scaffolding proteins | 2.39e-04 | 4 | 115 | 2 | 469 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 2.39e-04 | 4 | 115 | 2 | 833 | |
| GeneFamily | Complement system|Sushi domain containing | 1.54e-03 | 36 | 115 | 3 | 492 | |
| GeneFamily | Collagens | 3.12e-03 | 46 | 115 | 3 | 490 | |
| GeneFamily | ATP binding cassette subfamily A | 3.47e-03 | 14 | 115 | 2 | 805 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.68e-03 | 161 | 115 | 5 | 593 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.95e-03 | 50 | 115 | 3 | 1293 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.99e-03 | 15 | 115 | 2 | 26 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.71e-03 | 57 | 115 | 3 | 1179 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.02e-03 | 181 | 115 | 5 | 694 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 6.39e-03 | 19 | 115 | 2 | 50 | |
| Coexpression | LEE_BMP2_TARGETS_UP | COL7A1 ABCA1 ANPEP SLC2A8 ZBTB4 GPX2 DTX3L SNX21 REV3L CHKB METTL26 THBS3 LIPE PIK3R1 SCARB1 RIMS1 TCTN1 | 5.19e-06 | 780 | 158 | 17 | M2324 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | PDXDC1 TPO SMG1 SRSF10 ANPEP CELA2A PSMB7 NCAM1 SETDB1 LIPE STXBP2 ADSS2 NACC2 PIK3R1 SORBS3 SLC25A19 MYBL1 | 5.74e-06 | 786 | 158 | 17 | M2388 |
| Coexpression | NABA_CORE_MATRISOME | COL7A1 COL10A1 LAMA5 MMRN1 IGSF10 THBS3 ACAN COL14A1 ZP4 USH2A | 7.02e-06 | 275 | 158 | 10 | M5884 |
| Coexpression | LEE_BMP2_TARGETS_UP | COL7A1 ABCA1 ANPEP SLC2A8 ZBTB4 GPX2 DTX3L SNX21 REV3L CHKB METTL26 THBS3 LIPE PIK3R1 SCARB1 RIMS1 TCTN1 | 7.85e-06 | 805 | 158 | 17 | MM1067 |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 8.43e-06 | 79 | 158 | 6 | M7102 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | PDXDC1 TPO SMG1 SRSF10 ANPEP CELA2A PSMB7 NCAM1 SETDB1 LIPE STXBP2 ADSS2 NACC2 PIK3R1 SORBS3 SLC25A19 MYBL1 | 2.16e-05 | 871 | 158 | 17 | MM1005 |
| Coexpression | GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 3.03e-05 | 200 | 158 | 8 | M8547 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.38e-07 | 177 | 158 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.77e-07 | 188 | 158 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.93e-07 | 189 | 158 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.21e-07 | 134 | 158 | 7 | d63fff23040eada31bc35ba1e05b7c6a663e0037 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.61e-06 | 179 | 158 | 7 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-06 | 181 | 158 | 7 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.93e-06 | 122 | 158 | 6 | 1720756e0b3e8db14a9ccabe83f9b41689a4f754 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 5.34e-06 | 190 | 158 | 7 | bfb16efb23add53eebabc8e48f20c96994ec01da | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.53e-06 | 191 | 158 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.92e-06 | 193 | 158 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 196 | 158 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 196 | 158 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 196 | 158 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.77e-06 | 197 | 158 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.23e-06 | 199 | 158 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-05 | 150 | 158 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 94 | 158 | 5 | 00b932421d77f0fd8d6ffe439c992ebc95ad7c94 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 166 | 158 | 6 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 169 | 158 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 172 | 158 | 6 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 172 | 158 | 6 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-05 | 173 | 158 | 6 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-05 | 173 | 158 | 6 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 174 | 158 | 6 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.83e-05 | 175 | 158 | 6 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 175 | 158 | 6 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.83e-05 | 175 | 158 | 6 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 3.95e-05 | 176 | 158 | 6 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 3.95e-05 | 176 | 158 | 6 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.95e-05 | 176 | 158 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.08e-05 | 177 | 158 | 6 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.08e-05 | 177 | 158 | 6 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.08e-05 | 177 | 158 | 6 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.17e-05 | 108 | 158 | 5 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.17e-05 | 108 | 158 | 5 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.34e-05 | 179 | 158 | 6 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.34e-05 | 179 | 158 | 6 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.34e-05 | 179 | 158 | 6 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.76e-05 | 182 | 158 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 158 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.06e-05 | 184 | 158 | 6 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.21e-05 | 185 | 158 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-05 | 186 | 158 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 5.37e-05 | 186 | 158 | 6 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-05 | 186 | 158 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.53e-05 | 187 | 158 | 6 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.53e-05 | 187 | 158 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.70e-05 | 188 | 158 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.70e-05 | 188 | 158 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.70e-05 | 188 | 158 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-05 | 189 | 158 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-05 | 116 | 158 | 5 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.04e-05 | 190 | 158 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 6.04e-05 | 190 | 158 | 6 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 6.04e-05 | 190 | 158 | 6 | c5c80a6b9087821a2e07250fa90bcd3505f103b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.04e-05 | 190 | 158 | 6 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 158 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | droplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 191 | 158 | 6 | 1b59f1cad6c1a6a5938afa9195164918e3ff4e86 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.40e-05 | 192 | 158 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-05 | 192 | 158 | 6 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.59e-05 | 193 | 158 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 6.98e-05 | 195 | 158 | 6 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 195 | 158 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.98e-05 | 195 | 158 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.98e-05 | 195 | 158 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 195 | 158 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 196 | 158 | 6 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 196 | 158 | 6 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.18e-05 | 196 | 158 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.18e-05 | 196 | 158 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 196 | 158 | 6 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 196 | 158 | 6 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 7.18e-05 | 196 | 158 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-05 | 196 | 158 | 6 | fec21383435779bf4c632decd3d29c6ca7baebfb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.38e-05 | 197 | 158 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-05 | 197 | 158 | 6 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 7.38e-05 | 197 | 158 | 6 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.38e-05 | 197 | 158 | 6 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.80e-05 | 199 | 158 | 6 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.80e-05 | 199 | 158 | 6 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.80e-05 | 199 | 158 | 6 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.02e-05 | 200 | 158 | 6 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 200 | 158 | 6 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.02e-05 | 200 | 158 | 6 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 200 | 158 | 6 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 200 | 158 | 6 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.06e-05 | 124 | 158 | 5 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.02e-05 | 127 | 158 | 5 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.37e-05 | 128 | 158 | 5 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 130 | 158 | 5 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 130 | 158 | 5 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 133 | 158 | 5 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-04 | 141 | 158 | 5 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| Drug | chondroitin sulfate | COL7A1 COL10A1 NT5E LAMA5 CHSY1 NCAM1 MMRN1 THBS3 ADAMTS7 ACAN ADAMTS18 COL14A1 C4A | 5.70e-06 | 413 | 156 | 13 | CID000024766 |
| Drug | MDL 11,939 | 7.59e-06 | 19 | 156 | 4 | CID000071781 | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.32e-06 | 195 | 156 | 9 | 2278_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 9.41e-06 | 198 | 156 | 9 | 6687_DN | |
| Disease | autistic disorder (is_implicated_in) | 2.64e-06 | 42 | 154 | 5 | DOID:12849 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | BOC COL7A1 ABCA1 SLC66A2 CAD TTLL3 ABCA12 FSTL5 FRMPD2 ABCC5 CD46 NLGN4X ADAMTS18 PRKD1 PZP | 4.43e-06 | 702 | 154 | 15 | C0009402 |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | GALNT3 DPP8 CHKB SGCZ ABCB9 PTPRO ZMIZ2 PRKD1 BSN MAST3 AFG1L | 8.40e-06 | 398 | 154 | 11 | EFO_0003756, EFO_0003888, EFO_0004337 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.58e-05 | 152 | 154 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | recessive dystrophic epidermolysis bullosa (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0060642 (implicated_via_orthology) | |
| Disease | irritable bowel syndrome, anorexia nervosa | 8.09e-05 | 3 | 154 | 2 | EFO_0000555, MONDO_0005351 | |
| Disease | Congenital myopathy with fiber type disproportion | 4.00e-04 | 6 | 154 | 2 | cv:C0546264 | |
| Disease | Autistic Disorder | 4.60e-04 | 261 | 154 | 7 | C0004352 | |
| Disease | coronary artery disease | ABCA1 BCAR1 CHKB F13A1 OPHN1 NEDD9 IGSF10 SGCZ STXBP2 ADAMTS7 PTPRO ELFN1 SCARB1 EDEM2 MRPL40 BSN | 5.31e-04 | 1194 | 154 | 16 | EFO_0001645 |
| Disease | cognitive function measurement, self reported educational attainment | 5.78e-04 | 355 | 154 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | body surface area | PDXDC1 EEF1AKMT4-ECE2 CALCR ZBTB4 CHSY1 SPRYD7 PIK3R1 ACAN CADPS2 FUBP3 AFG1L | 5.85e-04 | 643 | 154 | 11 | EFO_0022196 |
| Disease | Complement deficiency disease | 6.78e-04 | 33 | 154 | 3 | C0272242 | |
| Disease | post-traumatic stress disorder | 6.93e-04 | 202 | 154 | 6 | EFO_0001358 | |
| Disease | sexual dimorphism measurement | PDXDC1 COL7A1 ABCA1 ZBTB4 CHSY1 BPTF SETDB1 PIK3R1 ACAN SCARB1 EDEM2 BSN FUBP3 TP53BP1 AFG1L | 7.05e-04 | 1106 | 154 | 15 | EFO_0021796 |
| Disease | pantothenate measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0021034 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 7.68e-04 | 206 | 154 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | Depression, Bipolar | 7.91e-04 | 79 | 154 | 4 | C0005587 | |
| Disease | cholesterol in large HDL measurement | 8.29e-04 | 80 | 154 | 4 | EFO_0021900 | |
| Disease | Disorder of eye | 8.91e-04 | 212 | 154 | 6 | C0015397 | |
| Disease | age at onset, coronary stenosis | 9.51e-04 | 9 | 154 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | low tension glaucoma | 9.51e-04 | 9 | 154 | 2 | EFO_1001022 | |
| Disease | Sclerocystic Ovaries | 9.75e-04 | 144 | 154 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 9.75e-04 | 144 | 154 | 5 | C0032460 | |
| Disease | neuroticism measurement | NPHP1 PCLO NCAM1 F13A1 MMRN1 LHX2 SGCZ FAM120A NLGN4X NACC2 SCARB1 PRKD1 SDK1 | 9.98e-04 | 909 | 154 | 13 | EFO_0007660 |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0008200 | |
| Disease | reticulocyte count | EEF1AKMT4-ECE2 FLNB ABCA1 PSMB7 PRPF8 MAST2 PABPC1 KAT2B PIK3R1 MAST1 C4B BSN SLC25A19 AFG1L | 1.19e-03 | 1045 | 154 | 14 | EFO_0007986 |
| Disease | renal cell carcinoma | 1.38e-03 | 42 | 154 | 3 | EFO_0000681 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 1.44e-03 | 11 | 154 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | campesterol measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0020008 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.48e-03 | 43 | 154 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.48e-03 | 43 | 154 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | unipolar depression | TRIT1 RNGTT SLC2A8 HSPA4L PCLO NCAM1 MANEA CLCC1 BPTF SGCZ FAM120A MRPL40 PRKCSH PZP SDK1 | 1.67e-03 | 1206 | 154 | 15 | EFO_0003761 |
| Disease | complement factor H-related protein 3 measurement | 1.98e-03 | 169 | 154 | 5 | EFO_0600056 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.03e-03 | 13 | 154 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.03e-03 | 13 | 154 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.03e-03 | 13 | 154 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 2.03e-03 | 13 | 154 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 2.03e-03 | 13 | 154 | 2 | C0752282 | |
| Disease | aortic measurement | 2.10e-03 | 251 | 154 | 6 | EFO_0020865 | |
| Disease | depressive symptom measurement, stressful life event measurement | 2.28e-03 | 50 | 154 | 3 | EFO_0007006, EFO_0007781 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.36e-03 | 14 | 154 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 2.36e-03 | 14 | 154 | 2 | C0410207 | |
| Disease | Hepatitis C | 2.72e-03 | 15 | 154 | 2 | C0019196 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 2.72e-03 | 15 | 154 | 2 | C3645536 | |
| Disease | amenorrhea, response to antineoplastic agent | 2.72e-03 | 15 | 154 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Metastatic melanoma | 2.85e-03 | 54 | 154 | 3 | C0278883 | |
| Disease | aspartate aminotransferase measurement | FLNB ABCA1 SLC66A2 ANPEP MANEA CHKB SETDB1 PIK3R1 SCARB1 RHOBTB2 EDEM2 GOT2 | 2.88e-03 | 904 | 154 | 12 | EFO_0004736 |
| Disease | neuroticism measurement, cognitive function measurement | 3.00e-03 | 566 | 154 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | vision disorder | 3.10e-03 | 16 | 154 | 2 | MONDO_0021084 | |
| Disease | cutaneous Leishmaniasis | 3.10e-03 | 16 | 154 | 2 | EFO_0005046 | |
| Disease | Cannabis use | 3.10e-03 | 16 | 154 | 2 | EFO_0007585 | |
| Disease | triglycerides in LDL measurement | 3.16e-03 | 56 | 154 | 3 | EFO_0022320 | |
| Disease | basal cell carcinoma | 3.20e-03 | 189 | 154 | 5 | EFO_0004193 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.25e-03 | 274 | 154 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.36e-03 | 276 | 154 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Colorectal Neoplasms | 3.42e-03 | 277 | 154 | 6 | C0009404 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.58e-03 | 194 | 154 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | reticulocyte measurement | FLNB ABCA1 HSPA4L PSMB7 PRPF8 PABPC1 KAT2B PIK3R1 MAST1 PRKCSH BSN SLC25A19 AFG1L | 3.60e-03 | 1053 | 154 | 13 | EFO_0010700 |
| Disease | fibroblast growth factor basic measurement | 3.66e-03 | 59 | 154 | 3 | EFO_0008130 | |
| Disease | Bipolar Disorder | 3.69e-03 | 477 | 154 | 8 | C0005586 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 3.84e-03 | 60 | 154 | 3 | EFO_0022282 | |
| Disease | Congenital Fiber Type Disproportion | 3.92e-03 | 18 | 154 | 2 | C0546264 | |
| Disease | free cholesterol in HDL measurement | 4.02e-03 | 61 | 154 | 3 | EFO_0022264 | |
| Disease | triglycerides in medium LDL measurement | 4.21e-03 | 62 | 154 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 4.21e-03 | 62 | 154 | 3 | EFO_0022339 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.37e-03 | 19 | 154 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | triglycerides in small LDL measurement | 4.81e-03 | 65 | 154 | 3 | EFO_0022323 | |
| Disease | Familial aplasia of the vermis | 4.83e-03 | 20 | 154 | 2 | cv:C0431399 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 4.83e-03 | 20 | 154 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | irritable bowel syndrome | 5.01e-03 | 131 | 154 | 4 | EFO_0000555 | |
| Disease | verbal-numerical reasoning measurement | 5.01e-03 | 131 | 154 | 4 | EFO_0008394 | |
| Disease | total lipids in very large HDL measurement | 5.02e-03 | 66 | 154 | 3 | EFO_0022312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKKRPGGRPEVIYNY | 381 | Q9BSF8 | |
| GGRPEVIYNYVQRPF | 386 | Q9BSF8 | |
| RIPYLPAAGEVEQYK | 496 | P0C7U0 | |
| QGVYDIPPTKGVYAI | 211 | Q14511 | |
| IQARYIYGKPVQGVA | 266 | P0C0L5 | |
| IYGKPVQGVAYVRFG | 271 | P0C0L5 | |
| KVVVPTRVGQGYVYE | 211 | P56945 | |
| IIPRGKGLGYAQYLP | 596 | Q9Y4W6 | |
| YPTIEPKPFLYVVGR | 31 | P30988 | |
| PLVYYQVEQRPVLGV | 416 | Q9H175 | |
| LGRILYAPYNPVTKA | 806 | Q86UK0 | |
| YIEAVFPGQYGIPRP | 841 | O95477 | |
| VDVGKSPNIPYVYIR | 126 | P46098 | |
| SKPPRGLYVYGDVGT | 126 | Q8WV93 | |
| PASENVPLIGKYYIA | 291 | Q9UGM1 | |
| YYLGNVPVAKPVGVD | 546 | O00213 | |
| PYLTPNDRGLYVFKG | 91 | P15144 | |
| TYPPYVTRVVGGEEA | 21 | P08217 | |
| YDGKRSLYTANPLPV | 86 | Q9H9G7 | |
| YGVFPEGRLEQYIPS | 136 | Q9Y259 | |
| GQLLPGRYYSKPFVT | 341 | Q9BYV7 | |
| GGIREVPYFNYNAKP | 1861 | Q12830 | |
| PASVPEYTGPRLYKE | 1101 | Q9P1Y5 | |
| DKPAPNTFYVGIYIL | 51 | P60033 | |
| RDYKPIGYINTPGPV | 606 | Q96MT7 | |
| ANEYYPVVLIPAGAR | 761 | Q8TE60 | |
| TQPTPKYKGRYCVGE | 566 | Q9UKP4 | |
| KYIPRRAVLYVPGND | 41 | Q8N0X4 | |
| YGAGLGVVERPYVPQ | 701 | P20742 | |
| GVVERPYVPQLGTYN | 706 | P20742 | |
| KLPGQPTIEGYLYTQ | 261 | O60890 | |
| PYTVPNKKGTRLGRY | 231 | Q99436 | |
| LPVYTPEVVAAYRGK | 131 | P12883 | |
| AYQVVSPGVYKSRAP | 186 | A8MYP8 | |
| RTVPQYKYAAGVRNP | 506 | P11940 | |
| VPGEAPGQPYRALYK | 221 | Q9Y257 | |
| PGQPYRALYKVLVTV | 226 | Q9Y257 | |
| KYIYNRSPAIAAVGP | 456 | O75439 | |
| ARDKIPIVVGGTNYY | 111 | Q9H3H1 | |
| PAGIILTKVGYYTIP | 731 | P52948 | |
| TPAYLAPEVLRNKGY | 746 | Q15139 | |
| EKYLVYRQVPGTDPA | 366 | P43364 | |
| LIGKPKPYYEIGERV | 46 | P15529 | |
| FAQARPPGIYKGDYL | 156 | O60942 | |
| PVKRTEAPGYYEVIR | 751 | Q92831 | |
| VLPQVYVYSGPEGRQ | 411 | P61550 | |
| TPNYIAPEVLLRKGY | 876 | Q9NRM7 | |
| VPNYLIPSGSREYKE | 466 | P59045 | |
| VKPYVNGTSPVYSRE | 1061 | Q9P2D0 | |
| TPRTGKFRIPYLGVY | 1131 | Q13201 | |
| GYKPLYIPSNRVNDG | 81 | P14314 | |
| KQPVVYGDPYQSRLD | 1746 | Q9UPA5 | |
| PQGYTVEKREGYPLR | 356 | Q9BV94 | |
| YVPPAAGRYTIKVLF | 811 | O75369 | |
| GYSDPFVKVYLLPGR | 4726 | Q9Y6V0 | |
| RILGPEAFQQYVGPY | 456 | P07202 | |
| IYVYKAQGAGVTLPP | 676 | Q6P996 | |
| VDPSVYGYGVQKRPL | 46 | Q96I24 | |
| GQVSVKYPRLIYKPE | 486 | O94830 | |
| IGRYPQENKGTYIPV | 106 | P00488 | |
| LPYYNGVGTVQKGRP | 211 | P50458 | |
| KVVINPYFGLGAPDY | 246 | O00522 | |
| YQQKPGQAPRLLIYG | 56 | A0A087WSY6 | |
| RGYKNQAAIQGRPPY | 1006 | Q9NZB2 | |
| YIYILGGRDPITGVK | 436 | Q8WVZ9 | |
| YFPAGPGRKVIEYKS | 466 | Q13087 | |
| RVKEGYVPQEEVPVY | 31 | Q9BRP8 | |
| VAVPQPGRYALVVEY | 1101 | O15230 | |
| VGDVYPVYQPVGPKQ | 146 | O95169 | |
| GTYVEYIGRKKISPP | 71 | P27986 | |
| DKYNLIFIPSVGPGY | 346 | Q5SRI9 | |
| PEYIAPEVILRQGYG | 551 | Q9Y2H9 | |
| DKPGVRTVYLYPNQT | 646 | P16112 | |
| RPTKEGGYGLKSYQP | 21 | Q8N475 | |
| PGAQYQVVIYLRKGP | 501 | Q16827 | |
| STPAPYVKVYLLENG | 1571 | Q86UR5 | |
| YREAPKGVDQYPAVV | 336 | Q96MD2 | |
| TPGYVAPEVLAQKPY | 181 | Q14012 | |
| LPAPYVKVYLLDNGV | 1291 | Q9UQ26 | |
| IGKEYIIPSPGYRSV | 6 | O15440 | |
| EILGPVDQYLGVPYA | 61 | Q9NZ94 | |
| ILGPVEQYLGVPYAS | 66 | Q8NFZ3 | |
| EYPLYIEGGATPVVV | 836 | Q9P2Q2 | |
| YYLPTKNEIVFPAGI | 681 | P0DPD8 | |
| GYVVDRPQINGKYIL | 2471 | Q6WRI0 | |
| GRVYERPVAGPYITF | 706 | Q9BWV1 | |
| PGKRYPGIQRTAYLP | 651 | Q8TDB6 | |
| IGATVYPVAIKYDPQ | 341 | Q86UL3 | |
| VYYPTRGGKPDEVVV | 386 | Q05707 | |
| VKGYRIVYKPVSVPG | 856 | Q05707 | |
| SVPYGGIYVKSIVPG | 971 | Q68DX3 | |
| VYVPDLNPVISGYIK | 496 | Q14435 | |
| KYPTVLFIYGGPQVQ | 661 | Q6V1X1 | |
| PGRSLKFYGVYEPVI | 241 | Q6ZUT9 | |
| KFYGVYEPVICQRPG | 246 | Q6ZUT9 | |
| YRATGQSYKPVPAIQ | 586 | Q86UW7 | |
| TEVGLKGPTVPYYEK | 151 | Q13495 | |
| PERYSGDNIIYKPPG | 201 | Q9BS26 | |
| IVTYGKIPYPGRTNA | 436 | P07948 | |
| YIAPEVILRQGYGKP | 691 | Q6P0Q8 | |
| YIAPEVIFRQGYGKP | 546 | O60307 | |
| YQQKPGQAPRLLIYG | 56 | P01624 | |
| GYKVQYTPLTGLGQP | 261 | Q02388 | |
| KVRDPAGQEGYVPYN | 516 | Q8TE68 | |
| LKYVRPGGGYQPTFT | 86 | P18283 | |
| IYTVELKRYGGPLGI | 671 | Q9Y3R0 | |
| PSTLYLGGLPRKYVA | 91 | Q9ULX7 | |
| PEEPNGIILGYQIAY | 1401 | Q7Z5N4 | |
| AVRTLLGYGYNIEPP | 1041 | P21817 | |
| LPAGPRVYFLKGGYE | 116 | Q16690 | |
| RNLPYVYIPSKTDLG | 101 | Q9NX24 | |
| ILGPVEQYLGVPYAS | 66 | Q8N0W4 | |
| IPVQIPGYQYVSPEG | 226 | P10243 | |
| PPGKEVYAVVDLYGQ | 861 | Q96JN8 | |
| IQARYIYGKPVQGVA | 266 | P0C0L4 | |
| IYGKPVQGVAYVRFG | 271 | P0C0L4 | |
| YIYILGGRDPITGVK | 436 | Q86V97 | |
| KGNEGLVPRTYLEPY | 196 | O15259 | |
| YGVRVPDGIMAAYPA | 741 | Q05469 | |
| KPRALLITYGPYAIN | 131 | Q96S19 | |
| LITYGPYAINGKISP | 136 | Q96S19 | |
| AGIRRPEKPPYSYIA | 41 | Q12946 | |
| FYYRTVNGLQPPIKV | 186 | O75445 | |
| PVYVGGIPQELLNSY | 1836 | O75445 | |
| QPPEGRYNDITKVYT | 186 | Q9NQ50 | |
| YKQIGIDPPRGVLMY | 191 | P43686 | |
| APVYISEIAYPAVRG | 141 | Q9NY64 | |
| DYIGLPEIPIGAYQA | 446 | Q9NXP7 | |
| VPRPSELYYSKIGPA | 2246 | Q96Q15 | |
| IQPGPFRAVLKYLYT | 421 | Q9BYZ6 | |
| GEKPQVRERGPYVYR | 81 | Q8WTV0 | |
| PRTENAQLYPVGIYG | 16 | Q96LD1 | |
| PPQNVGEVYGVVKAY | 286 | P30520 | |
| PASGIRGTVYPVVYV | 151 | Q5W111 | |
| YGYNPSPVKPEGLRR | 1061 | Q15047 | |
| PYYTGRAIDGIVIQK | 206 | Q9NP78 | |
| GLYLPYKVLPVGDEV | 156 | P21589 | |
| AYRDDNGKPYVLPSV | 66 | P00505 | |
| IRPVPEYQKYGSVAF | 381 | O00116 | |
| GKYLYSAVDGQPPRR | 381 | Q86X52 | |
| YAERYQMPTGIKGPL | 21 | Q03692 | |
| PTEQGPYAKTYEGRR | 406 | Q96S66 | |
| RGMTVYGLPRQVYDP | 256 | P51911 | |
| VVILRYGPYSAAGLP | 6 | Q8N6V4 | |
| EVQYAPKLQGPVAVY | 411 | P13591 | |
| LIYYRFNTGPVGKGP | 611 | Q6P2Q9 | |
| SIDYPRVNYPKGFRG | 36 | Q5GAN3 | |
| GERVPYVIIYGTPGV | 2946 | O60673 | |
| GRYGPIVDVYVPLDF | 31 | O75494 | |
| AVALAYGIYKQDLPP | 176 | O95757 | |
| YNEATGGKYVPRAVL | 51 | P68371 | |
| SKYVLYTLAVIGPGP | 146 | Q969T3 | |
| APDKTGIRVYYSPPV | 1006 | O94964 | |
| ATLQEYPAIRYRKGP | 181 | Q15833 | |
| YPAIRYRKGPEDTAQ | 186 | Q15833 | |
| IPTAAKYEYGVPLQT | 201 | Q2MV58 | |
| GAAKVTFYPEPYPLV | 911 | Q9P1Z0 | |
| IKPPTYQVLEYGEAV | 446 | O60504 | |
| LREQYGLGPYEAVTP | 1596 | Q12888 | |
| YKQPAVEVPQYVGIR | 516 | Q9Y4R7 | |
| IGYPSYLAPEVIAQG | 151 | Q8TEA7 | |
| QVGYIRVKLYEGPQL | 886 | P49746 | |
| DVAMGYKYGQPIPRV | 196 | Q8IWU9 | |
| EVAYIDGQVLVPPGY | 1791 | P27708 | |
| PRQGVKRTYSEVYPG | 261 | Q8NF64 | |
| ERVVYQPGYPKSIAS | 1506 | Q6PGP7 | |
| IVKPIVYGNVARYFG | 21 | O95619 | |
| YRSEGPQVFYKGLAP | 166 | Q9HC21 | |
| VFGGVVPYVPQYRDI | 26 | Q8N2U9 | |
| YGVGDYPVVKLLRDP | 331 | Q12836 | |
| IFNPRKEPVYLSGYG | 231 | Q9NYU2 | |
| GYYEQTGVGPLPVVL | 621 | Q9NYU2 | |
| AGTAPLKLPRVSYYG | 211 | Q96BF6 |